• English
  • Sign In
  • Contact Us
×
Catalog Products » CS1/CRACC/SLAMF7, His & Avi, Human

CS1/CRACC/SLAMF7, His & Avi, Human

CS1/CRACC/SLAMF7, His & Avi, Human

Immobilized SLAMF7, His & Avi tag at 1 ug/ml (100 ul/Well). Dose response curve for Elotuzumab with the EC50 of 42.6 ng/ml determined by ELISA.

CS1/CRACC/SLAMF7, His & Avi, Human

Recombinant Human CRACC/SLAMF7 Protein on SDS-PAGE under reducing conditions, the purity is greater than 95%.

CS1/CRACC/SLAMF7, His & Avi, Human

The purity of Recombinant Human CRACC/SLAMF7 Protein is greater than 95% as determined by SEC-HPLC.

CS1/CRACC/SLAMF7, His & Avi, Human

Immobilized SLAMF7, His & Avi tag at 1 ug/ml (100 ul/Well). Dose response curve for Elotuzumab with the EC50 of 42.6 ng/ml determined by ELISA.

CS1/CRACC/SLAMF7, His & Avi, Human

Recombinant Human CRACC/SLAMF7 Protein on SDS-PAGE under reducing conditions, the purity is greater than 95%.

CS1/CRACC/SLAMF7, His & Avi, Human

The purity of Recombinant Human CRACC/SLAMF7 Protein is greater than 95% as determined by SEC-HPLC.

Species Human
Protein Construction

SLAMF7 (Ser23-Met226)
Accession # Q9NQ25
Poly-His Avi
N-term C-term
Purity > 95% as analyzed by SDS-PAGE
> 95% as analyzed by HPLC
Endotoxin Level ≤ 1 EU/μg of protein by LAL method
Biological Activity Immobilized SLAMF7, His & Avi Tag at 1.0 ug/ml (100 ul/Well). Dose response curve for Elotuzumab with the EC50 of 42.6 ng/ml determined by ELISA.
Expression System Expi293
Apparent Molecular Weight 40~50 kDa, on SDS-PAGE under reducing conditions.
Formulation Lyophilized from a 0.22 μm filtered solution in PBS, pH 7.4. Normally 5 % trehalose is added as protectant before lyophilization.
Reconstitution It is recommended that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute the lyophilized powder in distilled water up to 100 μg/ml.
Storage & Stability Upon receiving, this product remains stable for up to 6 months at -70°C or -20°C. Avoid repeated freeze-thaw cycles.

  • CS1/CRACC/SLAMF7, His & Avi, Human
  • CS1/CRACC/SLAMF7, His & Avi, Human

    Immobilized SLAMF7, His & Avi tag at 1 ug/ml (100 ul/Well). Dose response curve for Elotuzumab with the EC50 of 42.6 ng/ml determined by ELISA.

  • CS1/CRACC/SLAMF7, His & Avi, Human
  • CS1/CRACC/SLAMF7, His & Avi, Human

    Recombinant Human CRACC/SLAMF7 Protein on SDS-PAGE under reducing conditions, the purity is greater than 95%.

  • CS1/CRACC/SLAMF7, His & Avi, Human
  • CS1/CRACC/SLAMF7, His & Avi, Human

    The purity of Recombinant Human CRACC/SLAMF7 Protein is greater than 95% as determined by SEC-HPLC.

  • CS1/CRACC/SLAMF7, His & Avi, Human
  • CS1/CRACC/SLAMF7, His & Avi, Human

    Immobilized SLAMF7, His & Avi tag at 1 ug/ml (100 ul/Well). Dose response curve for Elotuzumab with the EC50 of 42.6 ng/ml determined by ELISA.

  • CS1/CRACC/SLAMF7, His & Avi, Human
  • CS1/CRACC/SLAMF7, His & Avi, Human

    Recombinant Human CRACC/SLAMF7 Protein on SDS-PAGE under reducing conditions, the purity is greater than 95%.

  • CS1/CRACC/SLAMF7, His & Avi, Human
  • CS1/CRACC/SLAMF7, His & Avi, Human

    The purity of Recombinant Human CRACC/SLAMF7 Protein is greater than 95% as determined by SEC-HPLC.


Target Background CD2-like receptor activating cytotoxic cells (CRACC), also known as CS1, novel Ly9, SLAMF7, and CD319, is a 65-75 kDa type I transmembrane glycoprotein in the SLAM subgroup of the CD2 family, a self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. SLAM receptors triggered by homo- or heterotypic cell-cell interactions are modulating the activation and differentiation of a wide variety of immune cells and thus are involved in the regulation and interconnection of both innate and adaptive immune responses.
Synonyms CD319 antigen; CD319; 19A; CD2 subset 1; CD2-like receptor activating cytotoxic cells; CRACC; CRACCCD2-like receptor-activating cytotoxic cells; CS119A24 protein; Membrane protein FOAP-12; novel LY9 (lymphocyte antigen 9) like protein; Novel Ly9; Protein 19A; SLAM family member 7; SLAMF7; CS1

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.




Notice there is no results found, you can visit "Citations Database" for other results.





For more documents, please visit "Technical Support".

Cat. No. Z03649
Size Price
100 μg $200.00